Kwality Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2026 ,inter alia, to consider and approve the Standalone & Consolidated ....
KPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kwality Pharmaceuticals has informed BSE that its Board of Directors meeting is scheduled for May 19, 2026 to consider and approve the standalone and consolidated audited financial results for Q4 and the financial year ended March 31, 2026. The company has also closed its trading window for directors and designated persons until 48 hours after the results are made public. This is a routine regulatory intimation under SEBI Listing Regulations and does not contain any actual financial figures or decisions.
This is a standard procedural filing and does not contain any material financial information. Investors should await the actual financial results scheduled to be released on May 19, 2026 for any investment-relevant data.